Investors that are stuck higher could buy lower and average down as I have done This is go back up above .03 cents if it continues to deliver on the revenues it did in October The market can’t ignore solid revenues results and a low market cap imo
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential